Every finding on this page is sourced directly from the Provincial Auditor of Saskatchewan and federal health authorities. Medisyns does not manufacture the problem — it is documented in official records.
Source integrity policy: Every statistic on this page is cited with its primary source URL. We do not use secondary sources, industry estimates, or aggregator sites. If a number cannot be traced to a government document, auditor report, or peer-reviewed study, it does not appear here. Sources are dated — where data is from an earlier audit, this is noted explicitly.
The Saskatchewan Ministry of Health does not actively monitor the dispensing practices of the province's 385 pharmacies, and does not know whether those practices contribute to prescription drug misuse. A risk-based monitoring approach does not exist. There is no mechanism to detect whether pharmacies are properly dispensing opioids or other controlled substances.
For the six most commonly prescribed opioids, Saskatchewan's defined daily doses of 6,616 per 1,000 population is well above the national average of 5,479 per 1,000 population — a 21% premium over the national rate. The Provincial Auditor found the Ministry did not monitor all opioids prescribed in Saskatchewan, including ones known to cause overdose or death.
Among 19 Canadian cities with populations over 100,000, Regina ranked first for opioid poisoning hospitalization rates at 28.3 per 100,000 people in 2016–17. Saskatoon ranked second at 26.1 per 100,000. Both are dramatically higher than Toronto (7.9) and Vancouver (20.5). The Provincial Auditor linked these rates directly to the absence of adequate prescribing and dispensing monitoring.
In 2018–19, Saskatchewan pharmacies filled 441,354 opioid prescriptions for 98,947 individuals. The majority were hydromorphone (45%), codeine (32%), and morphine (10%). A further 359,681 prescriptions were dispensed for opioid addiction treatment. None of these dispensing events were subject to active provincial monitoring at the pharmacy level.
Data currency note: The most recent Saskatchewan Provincial Auditor performance audit of opioid prescribing and dispensing was published in 2019 (audit period ending February 2019). The 2024 and 2025 Auditor reports do not contain updated drug plan monitoring findings. These figures are presented as audited — Medisyns does not extrapolate or update them.
The Provincial Auditor confirmed the Ministry does not actively monitor dispensing and has no risk-based approach to identify pharmacy-level concerns. Medisyns is infrastructure: every dispense event generates a real-time verification record, a cross-system duplication check, and a timestamped audit entry. The monitoring gap the Auditor identified in 2019 is precisely what the Medisyns protocol layer closes.
Saskatchewan has no fraud rate because it has no detection system. Every Medisyns transaction establishes a data point that has never previously existed.
Duplicate prescriptions filled at different pharmacies are only detectable with a cross-system verification layer. Medisyns is that layer.
Replaces periodic inspection with a real-time log of every dispense event — timestamped, party-identified, and cryptographically verified.
Medisyns is in active conversations with provincial health systems. If you work in or with provincial health policy, procurement, or health IT — we'd like to talk.